Ultrasound Gastroscopes Market Overview
Ultrasound Gastroscopes Market Size was valued at USD 0.66 Billion in 2023. The Global Ultrasound Gastroscopes industry is projected to grow from USD 0.70 Billion in 2024 to USD 1.02 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.33% during the forecast period (2024 - 2032).
Ultrasound Gastroscopes are used by surgeons and physicians to diagnose and treat various conditions of the gastrointestinal tract such as gastrointestinal cancers, pancreatic conditions, and others. The factors such as the rising prevalence of gastric cancers, including upper and lower GI cancers, higher accuracy and specificity of endoscopy ultrasound techniques for the diagnosis of these conditions, technological advancements are some of the major factors propelling the ultrasound gastroscopes market.
According to the National Cancer Institute, there were about 26,240 cases of stomach cancer reported in the US in 2017. Likewise, as per the data by the American Cancer Society (ACS), nearly 53,070 people in the US were diagnosed with pancreatic cancer in 2016, and an estimated 41,000 deaths were related to pancreatic cancer in 2016. Despite the drivers, the lack of skilled professionals and high cost associated with this device are considered to hamper the growth of the market over the forecast period.
Moreover, major companies in the market are involved in strategic collaborations, and new product launches to brace their position in the market. For instance, in August 2017, Pentax Medical launched Slim Linear Ultrasound Endoscope (EG-3270UK) in the US.
Ultrasound Gastroscopes Market Segmentation
The Global Ultrasound Gastroscopes Market has been segmented into product type, application, procedure, and end-user. The market on the basis of product type has been segmented into optic ultrasound gastroscope, linear array ultrasound gastroscope, endoscopic ultrasound needle, and others.
Based on application, the market has been segmented into oncology, pancreatic conditions, and others. Further, the oncology segment has been segmented into upper gastrointestinal (GI) oncology and lower gastrointestinal (GI) oncology.
On the basis of procedure, the global market has been segmented into upper endoscopy ultrasound (EUS), lower endoscopy ultrasound (EUS), and Others. Furthermore, based on end-user, the market has been segmented into hospitals and clinics, ambulatory surgical centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The ultrasound gastroscopes market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European ultrasound gastroscopes market has been segmented into Western Europe and Eastern Europe.
Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The ultrasound gastroscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ultrasound gastroscopes market in the Middle East & Africa has been segmented into the Middle East and Africa.
Ultrasound Gastroscopes Market Key Players
- Olympus Corporation
- Fujifilm Holdings
- Karl Storz Endoscopy
- Cook Medical
- Medtronic plc
- Boston Scientific Corporation
- Esaote Spa
- Conmed Corporation
- Medi-Globe GmbH
Ultrasound Gastroscopes Market Regional Analysis
Geographically, the Americas is expected to dominate the global ultrasound gastroscopes market due to the rising demand for advanced diagnostic techniques especially in oncology, availability of new and advanced products in the US, and growing prevalence of pancreatic cancers. According to the Canadian Cancer Society, in 2017, about 3,500 Canadians were diagnosed with stomach cancer.
Europe is likely to show a considerable amount of growth in the global ultrasound gastroscopes market during the forecast period. The market growth in this region is due to the increasing incidence of gastrointestinal diseases and the growing geriatric population. According to the report by the United European Gastroenterology published in 2014, mortality due to pancreatic cancer is higher in parts of the UK, Scandinavia, Eastern Europe, and the Netherlands. Additionally, the growing government support for research & development and availability of funds for research is expected to support the market growth in the region.
Asia-Pacific is the fastest-growing market for ultrasound gastroscopes owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries such as India and South Korea is likely to fuel the market growth in the region.
On the other hand, the Middle East & Africa has the lowest share of the market due to the poor access to treatment, and limited screening and diagnostic services for disease management in the region.
Market Segmentation:
By Product Type
- Optic Ultrasound Gastroscope
- Linear Array Ultrasound Gastroscope
- Endoscopic Ultrasound Needle
- Others
By Application
- Oncology
- Upper GI Oncology
- Lower GI Oncology
- Pancreatic Conditions
- Others
By Procedure
- Upper Endoscopic Ultrasound (EUS)
- Lower Endoscopic Ultrasound (EUS)
- Endoscopic Ultrasound-Guided Fine-Needle Aspiration
- Others
By End-User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
By Region
- Americas
- North America
- Latin America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
Intended Audience
- Medical Device Companies
- Research and Development (R&D) Companies
- Government Research Institutes
- Academic Institutes and Universities
- Venture Capitalists
Report Attribute/Metric |
Details |
Market Size 2032 |
 USD 1.02 Billion 2032 |
Compound Annual Growth Rate (CAGR) |
4.33% 2032 |
Base Year |
2021 |
Market Forecast Period |
2024-2032 |
Historical Data |
2018 - 2021 |
Market Forecast Units |
Value (USD Million) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product, technology, application, and end-users. |
Geographies Covered |
Americas, Europe, Asia Pacific and the Middle East and Africa |
Countries Covered |
China, Japan, India, Australia, South Korea, Australia, Rest of Asia-Pacific |
Key Companies Profiled |
Masimo. (the U.S.)BD. (U.S.)Smiths Group Plc. (the U.S.)F. Hoffmann-La Roche Ltd (Europe)Bayer AG (Europe)Rotech Healthcare Inc. (U.S.)Chart Industries (U.S.)ACare Technology (Asia Pacific) |
Key Market Opportunities |
Key market opportunities for the ultrasound gastroscopes market include advancements in minimally invasive procedures, growing prevalence of gastrointestinal diseases, and increasing demand for early cancer detection. |
Key Market Dynamics |
Key market dynamics for the ultrasound gastroscopes market include technological advancements, increasing prevalence of gastrointestinal diseases, growing demand for minimally invasive procedures, and rising healthcare expenditures. |
Ultrasound Gastroscopes Market Highlights:
Frequently Asked Questions (FAQ) :
Ultrasound gastroscopes market is projected to grow at a 4.33% CAGR between 2024-2032.
The Americas is expected to dominate the ultrasound gastroscopes market.
Increasing prevalence of gastric cancer is the key factor driving the ultrasound gastroscopes market.
High cost of devices and lack of skilled professionals may limit the ultrasound gastroscopes market growth.
Different end users of the ultrasound gastroscopes market include ambulatory surgical centers, hospitals and clinics, and others.